Hui‐Sheng Ai

1.2k total citations
49 papers, 687 citations indexed

About

Hui‐Sheng Ai is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Hui‐Sheng Ai has authored 49 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 16 papers in Genetics and 10 papers in Oncology. Recurrent topics in Hui‐Sheng Ai's work include Hematopoietic Stem Cell Transplantation (26 papers), Mesenchymal stem cell research (12 papers) and Acute Myeloid Leukemia Research (8 papers). Hui‐Sheng Ai is often cited by papers focused on Hematopoietic Stem Cell Transplantation (26 papers), Mesenchymal stem cell research (12 papers) and Acute Myeloid Leukemia Research (8 papers). Hui‐Sheng Ai collaborates with scholars based in China, Switzerland and United States. Hui‐Sheng Ai's co-authors include Mei Guo, Kai‐Xun Hu, Zhao Sun, Robert Chunhua Zhao, Yang Zeng, Chunjing Bian, Hong Zhou, Zhuo Yang, Qi‐Yun Sun and Jian‐Hui Qiao and has published in prestigious journals such as Blood, PLoS ONE and Signal Transduction and Targeted Therapy.

In The Last Decade

Hui‐Sheng Ai

46 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hui‐Sheng Ai China 13 319 291 169 163 109 49 687
Suijing Wu China 10 275 0.9× 155 0.5× 276 1.6× 111 0.7× 110 1.0× 27 661
Laetitia Boutin France 11 328 1.0× 124 0.4× 175 1.0× 137 0.8× 126 1.2× 15 680
Suxia Geng China 16 361 1.1× 350 1.2× 380 2.2× 180 1.1× 77 0.7× 67 971
Luciana Vinti Italy 15 274 0.9× 248 0.9× 219 1.3× 194 1.2× 87 0.8× 59 781
Bryone J. Kuss Australia 16 500 1.6× 279 1.0× 315 1.9× 235 1.4× 54 0.5× 86 991
Joan García‐López Spain 14 337 1.1× 510 1.8× 259 1.5× 210 1.3× 167 1.5× 20 1.1k
Kimberly L. Gandy United States 13 138 0.4× 238 0.8× 219 1.3× 117 0.7× 156 1.4× 32 790
Juana Merino Spain 14 307 1.0× 180 0.6× 238 1.4× 143 0.9× 319 2.9× 26 815
Chunji Gao China 16 256 0.8× 360 1.2× 258 1.5× 226 1.4× 114 1.0× 77 897
Maria‐Christina Kyrtsonis Greece 16 252 0.8× 445 1.5× 259 1.5× 298 1.8× 54 0.5× 18 806

Countries citing papers authored by Hui‐Sheng Ai

Since Specialization
Citations

This map shows the geographic impact of Hui‐Sheng Ai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui‐Sheng Ai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui‐Sheng Ai more than expected).

Fields of papers citing papers by Hui‐Sheng Ai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui‐Sheng Ai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui‐Sheng Ai. The network helps show where Hui‐Sheng Ai may publish in the future.

Co-authorship network of co-authors of Hui‐Sheng Ai

This figure shows the co-authorship network connecting the top 25 collaborators of Hui‐Sheng Ai. A scholar is included among the top collaborators of Hui‐Sheng Ai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui‐Sheng Ai. Hui‐Sheng Ai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lei, Yangyang, Xinrui Chen, Chang‐Lin Yu, et al.. (2023). Mechanisms of Thymic Repair of In Vitro-Induced Precursor T Cells as a Haploidentical Hematopoietic Stem Cell Transplantation Regimen. Transplantation and Cellular Therapy. 29(6). 382.e1–382.e11. 3 indexed citations
2.
Hu, Kai‐Xun, Mei Guo, Jian‐Hui Qiao, et al.. (2023). Hematopoietic stem cell microtransplantation in patients aged over 70 with acute myeloid leukemia: a multicenter study.. PubMed. 13(4). 1509–1521. 2 indexed citations
3.
Hu, Kai‐Xun, Hui‐Sheng Ai, Mei Guo, et al.. (2020). Donor Selection in HLA-Mismatched Hematopoietic Stem Cell Microtransplantation for Acute Myeloid Leukemia. Stem Cells and Development. 29(10). 648–654. 6 indexed citations
4.
Cai, Bo, Yao Wang, Zhiqiang Wu, et al.. (2020). Co-infusion of high-dose haploidentical donor cells and CD19-targeted CART cells achieves complete remission, successful donor engraftment and significant CART amplification in advanced ALL. Therapeutic Advances in Medical Oncology. 12. 3863542645–3863542645. 6 indexed citations
5.
Cai, Bo, Qi‐Yun Sun, Jian‐Hui Qiao, et al.. (2020). Comparison of microtransplantation, chemotherapy and allogeneic transplantation in post-remission therapy for Philadelphia chromosome-positive acute lymphoblastic leukemia.. PubMed. 10(11). 3852–3866. 5 indexed citations
7.
Wang, Junhui, Lu Wang, Yi Wang, et al.. (2017). [Biological Characteristics of Microvesicles Secreted by Human Peripheral Blood Hematopoietic Stem Cells].. PubMed. 25(3). 637–643. 1 indexed citations
8.
Yu, Li, Xin Du, Jie Jin, et al.. (2015). Lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed or refractory multiple myeloma and renal impairment. International Journal of Hematology. 101(6). 569–577. 7 indexed citations
9.
10.
Krakow, Elizabeth F., Hui‐Sheng Ai, Brian C. Shaffer, et al.. (2015). Do We Need Full Donor Chimerism? How Alloreactive Cell Therapies without Substantial Engraftment Might Treat Hematologic Cancers. Current Drug Targets. 18(3). 281–295. 10 indexed citations
11.
Sun, Xuedong, Mei Guo, Qi‐Yun Sun, et al.. (2014). The existence and role of microchimerism after microtransplantion. Leukemia Research. 38(11). 1285–1290. 7 indexed citations
12.
Zhang, Jiamin, Shiyuan Zhou, Yi Zhou, et al.. (2014). Hepatocyte Growth Factor Gene-Modified Adipose-Derived Mesenchymal Stem Cells Ameliorate Radiation Induced Liver Damage in a Rat Model. PLoS ONE. 9(12). e114670–e114670. 53 indexed citations
14.
Ai, Hui‐Sheng, Kai‐Xun Hu, Qi‐Yun Sun, et al.. (2012). Microtransplantation with Decitabine and Cytarabine Improves Patient Outcomes in Myelodysplastic Syndromes. Blood. 120(21). 1709–1709. 4 indexed citations
15.
Ai, Hui‐Sheng, et al.. (2012). [NK cell surface receptors and their research progress - review].. PubMed. 20(4). 1034–8. 1 indexed citations
16.
Guo, Mei, Kai‐Xun Hu, Chang‐Lin Yu, et al.. (2010). Infusion of HLA-mismatched peripheral blood stem cells improves the outcome of chemotherapy for acute myeloid leukemia in elderly patients. Blood. 117(3). 936–941. 66 indexed citations
17.
Hu, Kai‐Xun, et al.. (2010). The radiation protection and therapy effects of mesenchymal stem cells in mice with acute radiation injury. British Journal of Radiology. 83(985). 52–58. 72 indexed citations
18.
Bian, Li, Zi‐Kuan Guo, & Hui‐Sheng Ai. (2007). [Hepatocyte growth factor and its immunoregulatory activity - review].. PubMed. 15(2). 441–4. 1 indexed citations
19.
Liu, Lihui, Zhao Sun, Bin Chen, et al.. (2006). Ex Vivo Expansion and In Vivo Infusion of Bone Marrow–Derived Flk-1 + CD31 CD34 Mesenchymal Stem Cells: Feasibility and Safety from Monkey to Human. Stem Cells and Development. 15(3). 349–357. 47 indexed citations
20.
Liu, Lihui, Qi‐Yun Sun, Yajing Huang, et al.. (2005). [Establishment of rhesus model for haploidentical hematopoietic stem cell transplantation with nonmyeloablative conditioning].. PubMed. 13(4). 677–82. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026